<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03948854</url>
  </required_header>
  <id_info>
    <org_study_id>18-011391</org_study_id>
    <nct_id>NCT03948854</nct_id>
  </id_info>
  <brief_title>Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients</brief_title>
  <official_title>Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients: Which Educational Method Works Best</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are trying to determine the best course of action regarding the dietary
      management with a diet low in fermentable oligosaccharides, disaccharides, monosaccharides
      and polyols (FODMAP diet) for irritable bowel syndrome.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">May 22, 2019</start_date>
  <completion_date type="Anticipated">May 22, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 22, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in IBS symptoms</measure>
    <time_frame>Baseline, weekly for approximately 8 to 10 weeks</time_frame>
    <description>Measured using a weekly assessment questionnaire of significantly worse to significantly better</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>IBS - Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Registered dietitian education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with irritable bowel syndrome (IBS) will receive education on FODMAP diet in person by a registered dietitian</description>
  </arm_group>
  <arm_group>
    <arm_group_label>On-line video program education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with irritable bowel syndrome (IBS) will receive education on FODMAP diet using an on-line video program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Handout education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with irritable bowel syndrome (IBS) will receive education on FODMAP diet by a printed handout</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietitian-led group education</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with irritable bowel syndrome (IBS) will receive education on FODMAP diet in a dietitian-led group setting</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Registered dietitian</intervention_name>
    <description>Education on low FODMAP diet is provided in person by a registered dietitian who is an expert on the low FODMAP diet</description>
    <arm_group_label>Registered dietitian education</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>On-line video program</intervention_name>
    <description>Education on low FODMAP diet is provided by an on-line program via a link sent through email</description>
    <arm_group_label>On-line video program education</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Printed handout</intervention_name>
    <description>Education on low FODMAP diet is provided through printed handout material at the initial visit.</description>
    <arm_group_label>Handout education</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietitian-led group</intervention_name>
    <description>Education on low FODMAP diet is provided in a dietitian-led group setting</description>
    <arm_group_label>Dietitian-led group education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult subjects (18-75 years) seen in the primary care clinic or in the
             Gastroenterology clinic at Mayo Clinic Florida, who are diagnosed with IBS by Rome IV
             criteria

        Exclusion Criteria:

          -  Subjects who have previously tried the low FODMAP diet (whether successful or not)

          -  Current or recent (less than 4 weeks) opioid use

          -  Current or recent (less than 10 weeks) rifaximin use

          -  Inability to speak or read English

          -  Pregnancy and/or breast-feeding

          -  Medical or psychological issues that would prevent modifying their diet for 8 weeks.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Lacy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 10, 2019</study_first_submitted>
  <study_first_submitted_qc>May 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2019</study_first_posted>
  <last_update_submitted>May 13, 2019</last_update_submitted>
  <last_update_submitted_qc>May 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Brian E. Lacy</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

